Skip to content

Trimas TRS Finance Lease Liability Payments Due Year Three

Finance Lease Liability Payments Due Year Three at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Chart Industries logo
Chart IndustriesGTLS

Other financials

Income statement

See full
Revenue$168.3M+10.4%
Gross profit$36.9M+12.3%
Operating income$6.9M-3.6%
Net income$800.8M+6,348%
EPS (diluted)$21.40+7,033%

Balance sheet

See full
Cash & equivalents$1.3B+3,904%
Total debt$439.9M-9.2%
Total equity$1.4B+111%
Total assets$2.3B+64.8%

Cash flow

See full
Operating cash flow-$19.4M-311%
CapEx$5.2M-59.7%
Free cash flow-$24.6M-556%

Valuation

See full
Market cap$1.56B+41.9%
Enterprise value$692.33M-65.6%
P/E1.7×-33.2×
P/S2.4×+0.6×

Profitability

See full
Gross margin-0.1%-2.1pp
Operating margin8%-1.0pp
Net margin137.3%+132pp
FCF margin7.3%+3.1pp

Returns & leverage

See full
Return on equity85.1%+80.4pp
Debt / equity0.3×-0.4×
Current ratio4.9×+2.0×

Where this comes from

Reported directly by Trimas in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree.

The official record: Trimas’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trimas's finance lease liability payments due year three.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trimas's finance lease liability payments due year three?
Trimas (TRS) reported finance lease liability payments due year three of $0 in Q1 2026.
What is the long-term trend for Trimas's finance lease liability payments due year three?
Over 2 years (2023 to 2025), Trimas's finance lease liability payments due year three has grown at a -100.0% compound annual growth rate (CAGR), from $600K to $0.